SCHEMBL2912641

SCHEMBL2912641

CCc1nc2cc(OC)c(N3CCCN(C)CC3)cc2c(Nc2ccc(Cl)c(Cl)c2)c1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 7/20 0.60
KCNH2 Q12809 4/20 0.44
SCN5A Q14524 2/20 0.44
CCNT1 O60563 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CDK9 P50750 1/20 0.42
CDK6 Q00534 1/20 0.42
CDK11A Q9UQ88 1/20 0.42
PAK1 Q13153 1/20 0.42
EPHA2 P29317 2/20 0.41
EPHB4 P54760 2/20 0.41
WEE1 P30291 1/20 0.41
EML4 Q9HC35 2/20 0.41
ALK Q9UM73 2/20 0.41
ERBB2 P04626 1/20 0.41
KDR P35968 1/20 0.41
BRD4 O60885 1/20 0.40
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911203 0.90 CSF1R (0.56) CSF1RKCNH2SCN5AEPHA2EPHB4
SCHEMBL2905929 0.88 CSF1R (0.53) CSF1RKCNH2SCN5ACCNT1CDK4
SCHEMBL2909682 0.83 CSF1R (0.64) CSF1RKCNH2SCN5A
SCHEMBL4433976 0.80 CSF1R (0.48) CSF1REPHA2EPHB4ERBB2KDR
SCHEMBL2907522 0.80 CSF1R (0.48) CSF1RKCNH2SCN5AERBB2
SCHEMBL2911700 0.80 KCNH2 (0.51) CSF1RKCNH2SCN5AKDRHTR1A
SCHEMBL2913360 0.79 SCN5A (0.52) CSF1RKCNH2SCN5AHTR1AHTR1D
SCHEMBL2908706 0.79 KCNH2 (0.46) CSF1RKCNH2SCN5AEML4ALK
SCHEMBL2912636 0.79 CSF1R (0.75) CSF1RKCNH2SCN5APAK1BRD4
SCHEMBL2911370 0.79 CSF1R (0.94) CSF1RKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010496-B1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2010-08-25 EP disclosed